Reliance Global (RELI) had the highest return between May 11, 2017 and May 15, 2017 by a US stock, returning 80.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Reliance Global (RELI) | 5/11/2017 - 5/15/2017 | 80.5% |
Atlas Lithium Corporation Common Stock (ATLX) | 5/11/2017 - 5/15/2017 | 66.67% |
BTCS (BTCS) | 5/11/2017 - 5/15/2017 | 61.91% |
Immunitybio (IBRX) | 5/11/2017 - 5/15/2017 | 52.82% |
Iqstel (IQST) | 5/11/2017 - 5/15/2017 | 42.86% |
Riley Exploration Permian (REPX) | 5/11/2017 - 5/15/2017 | 36.71% |
Trade Desk (TTD) | 5/11/2017 - 5/15/2017 | 33.62% |
Opus Genetics (IRD) | 5/11/2017 - 5/15/2017 | 32.31% |
Sangamo Therapeutics (SGMO) | 5/11/2017 - 5/15/2017 | 32.28% |
Novavax (NVAX) | 5/11/2017 - 5/15/2017 | 29.95% |
Zynex (ZYXI) | 5/11/2017 - 5/15/2017 | 29.14% |
Lightwave Logic (LWLG) | 5/11/2017 - 5/15/2017 | 27.01% |
Tantech (TANH) | 5/11/2017 - 5/15/2017 | 26.88% |
Xtant Medical (XTNT) | 5/11/2017 - 5/15/2017 | 26.58% |
Durect (DRRX) | 5/11/2017 - 5/15/2017 | 25.49% |
PharmaCyte Biotech (PMCB) | 5/11/2017 - 5/15/2017 | 25% |
RideNow (RDNW) | 5/11/2017 - 5/15/2017 | 25% |
Precigen (PGEN) | 5/11/2017 - 5/15/2017 | 23.95% |
Eastside Distilling (BLNE) | 5/11/2017 - 5/15/2017 | 23.72% |
Pulse Biosciences (PLSE) | 5/11/2017 - 5/15/2017 | 23.01% |
Ocular Therapeutix (OCUL) | 5/11/2017 - 5/15/2017 | 22.18% |
Ryvyl (RVYL) | 5/11/2017 - 5/15/2017 | 22.15% |
Nutex Health (NUTX) | 5/11/2017 - 5/15/2017 | 20% |
MDxHealth SA ADR (MDXH) | 5/11/2017 - 5/15/2017 | 20% |
Oragenics (OGEN) | 5/11/2017 - 5/15/2017 | 19.44% |
